PubMed:10383126
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-111 | Sentence | denotes | Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. |
| TextSentencer_T2 | 112-277 | Sentence | denotes | MYC gene overexpression was identified recently as a downstream step at the end of the Wnt/APC/beta-catenin pathway dysregulation observed in colorectal cancer (T-C. |
| TextSentencer_T3 | 278-318 | Sentence | denotes | He et al., Science (Washington DC), 281: |
| TextSentencer_T4 | 319-336 | Sentence | denotes | 1509-1512, 1998). |
| TextSentencer_T5 | 337-424 | Sentence | denotes | It thus appears that an excess of c-myc protein is a primary cause of numerous cancers. |
| TextSentencer_T6 | 425-568 | Sentence | denotes | In breast cancer, MYC has been studied mostly at the DNA level because of the poor quality of available antibodies against the protein product. |
| TextSentencer_T7 | 569-689 | Sentence | denotes | The renewed interest in MYC calls for a sensitive and accurate method for analyzing MYC overexpression in breast tumors. |
| TextSentencer_T8 | 690-843 | Sentence | denotes | We have developed a real-time quantitative reverse transcription-PCR assay based on TaqMan fluorescence methodology to quantify the MYC mRNA copy number. |
| TextSentencer_T9 | 844-903 | Sentence | denotes | We validated the method on a large series of breast tumors. |
| TextSentencer_T10 | 904-1043 | Sentence | denotes | MYC gene overexpression was observed in 29 of 134 (22%) breast tumor RNAs, ranging from 3.2 to 19 times the level in normal breast tissues. |
| TextSentencer_T11 | 1044-1209 | Sentence | denotes | These data imply that dysregulated MYC gene expression is potentially involved in the pathogenesis of breast cancer, especially by favoring local cell proliferation. |
| TextSentencer_T12 | 1210-1322 | Sentence | denotes | We also found that MYC gene overexpression was rarely due to an increased MYC gene copy number in breast cancer. |
| TextSentencer_T13 | 1323-1569 | Sentence | denotes | This new, simple, rapid, and semiautomated method will be useful for screening cancer patients for MYC overexpression and will prove a powerful tool in large, randomized, prospective, cooperative group trials and in the MYC-based therapy project. |
| T1 | 0-111 | Sentence | denotes | Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. |
| T2 | 112-277 | Sentence | denotes | MYC gene overexpression was identified recently as a downstream step at the end of the Wnt/APC/beta-catenin pathway dysregulation observed in colorectal cancer (T-C. |
| T3 | 278-318 | Sentence | denotes | He et al., Science (Washington DC), 281: |
| T4 | 319-336 | Sentence | denotes | 1509-1512, 1998). |
| T5 | 337-424 | Sentence | denotes | It thus appears that an excess of c-myc protein is a primary cause of numerous cancers. |
| T6 | 425-568 | Sentence | denotes | In breast cancer, MYC has been studied mostly at the DNA level because of the poor quality of available antibodies against the protein product. |
| T7 | 569-689 | Sentence | denotes | The renewed interest in MYC calls for a sensitive and accurate method for analyzing MYC overexpression in breast tumors. |
| T8 | 690-843 | Sentence | denotes | We have developed a real-time quantitative reverse transcription-PCR assay based on TaqMan fluorescence methodology to quantify the MYC mRNA copy number. |
| T9 | 844-903 | Sentence | denotes | We validated the method on a large series of breast tumors. |
| T10 | 904-1043 | Sentence | denotes | MYC gene overexpression was observed in 29 of 134 (22%) breast tumor RNAs, ranging from 3.2 to 19 times the level in normal breast tissues. |
| T11 | 1044-1209 | Sentence | denotes | These data imply that dysregulated MYC gene expression is potentially involved in the pathogenesis of breast cancer, especially by favoring local cell proliferation. |
| T12 | 1210-1322 | Sentence | denotes | We also found that MYC gene overexpression was rarely due to an increased MYC gene copy number in breast cancer. |
| T13 | 1323-1569 | Sentence | denotes | This new, simple, rapid, and semiautomated method will be useful for screening cancer patients for MYC overexpression and will prove a powerful tool in large, randomized, prospective, cooperative group trials and in the MYC-based therapy project. |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 10383126-0#16#19#gene4609 | 16-19 | gene4609 | denotes | MYC |
| 10383126-0#48#61#diseaseC1458155 | 48-61 | diseaseC1458155 | denotes | breast tumors |
| 10383126-1#0#3#gene4609 | 112-115 | gene4609 | denotes | MYC |
| 10383126-1#91#94#gene324 | 203-206 | gene324 | denotes | APC |
| 10383126-1#142#159#diseaseC0009402 | 254-271 | diseaseC0009402 | denotes | colorectal cancer |
| 10383126-1#142#159#diseaseC1527249 | 254-271 | diseaseC1527249 | denotes | colorectal cancer |
| 10383126-1#142#159#diseaseC0009402 | 254-271 | diseaseC0009402 | denotes | colorectal cancer |
| 10383126-1#142#159#diseaseC1527249 | 254-271 | diseaseC1527249 | denotes | colorectal cancer |
| 10383126-10#19#22#gene4609 | 1229-1232 | gene4609 | denotes | MYC |
| 10383126-10#74#77#gene4609 | 1284-1287 | gene4609 | denotes | MYC |
| 10383126-10#98#111#diseaseC0006142 | 1308-1321 | diseaseC0006142 | denotes | breast cancer |
| 10383126-10#98#111#diseaseC0678222 | 1308-1321 | diseaseC0678222 | denotes | breast cancer |
| 10383126-10#98#111#diseaseC0006142 | 1308-1321 | diseaseC0006142 | denotes | breast cancer |
| 10383126-10#98#111#diseaseC0678222 | 1308-1321 | diseaseC0678222 | denotes | breast cancer |
| 16#19#gene460948#61#diseaseC1458155 | 10383126-0#16#19#gene4609 | 10383126-0#48#61#diseaseC1458155 | associated_with | MYC,breast tumors |
| 0#3#gene4609142#159#diseaseC0009402 | 10383126-1#0#3#gene4609 | 10383126-1#142#159#diseaseC0009402 | associated_with | MYC,colorectal cancer |
| 0#3#gene4609142#159#diseaseC1527249 | 10383126-1#0#3#gene4609 | 10383126-1#142#159#diseaseC1527249 | associated_with | MYC,colorectal cancer |
| 0#3#gene4609142#159#diseaseC0009402 | 10383126-1#0#3#gene4609 | 10383126-1#142#159#diseaseC0009402 | associated_with | MYC,colorectal cancer |
| 0#3#gene4609142#159#diseaseC1527249 | 10383126-1#0#3#gene4609 | 10383126-1#142#159#diseaseC1527249 | associated_with | MYC,colorectal cancer |
| 91#94#gene324142#159#diseaseC0009402 | 10383126-1#91#94#gene324 | 10383126-1#142#159#diseaseC0009402 | associated_with | APC,colorectal cancer |
| 91#94#gene324142#159#diseaseC1527249 | 10383126-1#91#94#gene324 | 10383126-1#142#159#diseaseC1527249 | associated_with | APC,colorectal cancer |
| 91#94#gene324142#159#diseaseC0009402 | 10383126-1#91#94#gene324 | 10383126-1#142#159#diseaseC0009402 | associated_with | APC,colorectal cancer |
| 91#94#gene324142#159#diseaseC1527249 | 10383126-1#91#94#gene324 | 10383126-1#142#159#diseaseC1527249 | associated_with | APC,colorectal cancer |
| 19#22#gene460998#111#diseaseC0006142 | 10383126-10#19#22#gene4609 | 10383126-10#98#111#diseaseC0006142 | associated_with | MYC,breast cancer |
| 19#22#gene460998#111#diseaseC0678222 | 10383126-10#19#22#gene4609 | 10383126-10#98#111#diseaseC0678222 | associated_with | MYC,breast cancer |
| 19#22#gene460998#111#diseaseC0006142 | 10383126-10#19#22#gene4609 | 10383126-10#98#111#diseaseC0006142 | associated_with | MYC,breast cancer |
| 19#22#gene460998#111#diseaseC0678222 | 10383126-10#19#22#gene4609 | 10383126-10#98#111#diseaseC0678222 | associated_with | MYC,breast cancer |
| 74#77#gene460998#111#diseaseC0006142 | 10383126-10#74#77#gene4609 | 10383126-10#98#111#diseaseC0006142 | associated_with | MYC,breast cancer |
| 74#77#gene460998#111#diseaseC0678222 | 10383126-10#74#77#gene4609 | 10383126-10#98#111#diseaseC0678222 | associated_with | MYC,breast cancer |
| 74#77#gene460998#111#diseaseC0006142 | 10383126-10#74#77#gene4609 | 10383126-10#98#111#diseaseC0006142 | associated_with | MYC,breast cancer |
| 74#77#gene460998#111#diseaseC0678222 | 10383126-10#74#77#gene4609 | 10383126-10#98#111#diseaseC0678222 | associated_with | MYC,breast cancer |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1397 | 1229-1232 | gene:4609 | denotes | MYC |
| T1398 | 1308-1321 | disease:C0006142 | denotes | breast cancer |
| T1399 | 1284-1287 | gene:4609 | denotes | MYC |
| R1 | T1397 | T1398 | associated_with | MYC,breast cancer |
| R2 | T1397 | T1398 | associated_with | MYC,breast cancer |
| R3 | T1399 | T1398 | associated_with | MYC,breast cancer |
| R4 | T1399 | T1398 | associated_with | MYC,breast cancer |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 1035-1042 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| PD-UBERON-AE-B_T2 | 48-54 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T3 | 428-434 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T4 | 675-681 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T5 | 889-895 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T6 | 960-966 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T7 | 1028-1034 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T8 | 1146-1152 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T9 | 1308-1314 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 48-54 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T2 | 428-434 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T3 | 675-681 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T4 | 889-895 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T5 | 960-966 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T6 | 1028-1034 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T7 | 1146-1152 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T8 | 1308-1314 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T9 | 1035-1042 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 112-115 | gene:4609 | denotes | MYC |
| T1 | 254-271 | disease:C0009402 | denotes | colorectal cancer |
| T2 | 112-115 | gene:4609 | denotes | MYC |
| T3 | 254-271 | disease:C1527249 | denotes | colorectal cancer |
| T4 | 203-206 | gene:5624 | denotes | APC |
| T5 | 254-271 | disease:C0009402 | denotes | colorectal cancer |
| T6 | 203-206 | gene:324 | denotes | APC |
| T7 | 254-271 | disease:C1527249 | denotes | colorectal cancer |
| T8 | 203-206 | gene:324 | denotes | APC |
| T9 | 254-271 | disease:C0009402 | denotes | colorectal cancer |
| T10 | 203-206 | gene:5624 | denotes | APC |
| T11 | 254-271 | disease:C1527249 | denotes | colorectal cancer |
| T12 | 904-907 | gene:4609 | denotes | MYC |
| T13 | 960-972 | disease:C1458155 | denotes | breast tumor |
| R1 | T0 | T1 | associated_with | MYC,colorectal cancer |
| R2 | T2 | T3 | associated_with | MYC,colorectal cancer |
| R3 | T4 | T5 | associated_with | APC,colorectal cancer |
| R4 | T6 | T7 | associated_with | APC,colorectal cancer |
| R5 | T8 | T9 | associated_with | APC,colorectal cancer |
| R6 | T10 | T11 | associated_with | APC,colorectal cancer |
| R7 | T12 | T13 | associated_with | MYC,breast tumor |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 265-271 | HP_0002664 | denotes | cancer |
| T2 | 416-423 | HP_0002664 | denotes | cancers |
| T3 | 428-441 | HP_0003002 | denotes | breast cancer |
| T4 | 428-441 | HP_0100013 | denotes | breast cancer |
| T5 | 435-441 | HP_0002664 | denotes | cancer |
| T6 | 675-688 | HP_0003002 | denotes | breast tumors |
| T7 | 675-688 | HP_0100013 | denotes | breast tumors |
| T8 | 682-688 | HP_0002664 | denotes | tumors |
| T9 | 889-902 | HP_0003002 | denotes | breast tumors |
| T10 | 889-902 | HP_0100013 | denotes | breast tumors |
| T11 | 896-902 | HP_0002664 | denotes | tumors |
| T12 | 960-972 | HP_0003002 | denotes | breast tumor |
| T13 | 960-972 | HP_0100013 | denotes | breast tumor |
| T14 | 967-972 | HP_0002664 | denotes | tumor |
| T15 | 1146-1159 | HP_0003002 | denotes | breast cancer |
| T16 | 1146-1159 | HP_0100013 | denotes | breast cancer |
| T17 | 1153-1159 | HP_0002664 | denotes | cancer |
| T18 | 1308-1321 | HP_0003002 | denotes | breast cancer |
| T19 | 1308-1321 | HP_0100013 | denotes | breast cancer |
| T20 | 1315-1321 | HP_0002664 | denotes | cancer |
| T21 | 1402-1408 | HP_0002664 | denotes | cancer |